… are available for the treatment of COVID-19. Since there is no … treatments currently administered
in patients with COVID-19, … properties, their pharmacological features and achievement …

… the new coronavirus or coronavirus disease 2019 (COVID-19)… as Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-… The ongoing COVID-19 pandemic with significant mortality, …

… It is quite likely that the drugs we will use to treat COVID-19 will work through unknown or
unanticipated mechanisms. ACE inhibitors, Beta Blockers, statins, PDE-5 inhibitors, SGLT-2 …

… agents to both prevent and treat COVID-19. Although vaccines and specific drug … COVID-19.
In the present review, the drug candidates that have been suggested to treat COVID-19 will …

… health strategy to reduce the burden of COVID-19, the management of this disease …
pharmacological agents that have been developed and/or repurposed for the treatment of COVID-19. …

… treatment options, already existing pharmacological agents are repurposed for the potential
treatment of COVID-19 … repurposed pharmacological agents for the treatment of COVID-19 at …

… to treat symptoms, including non-pharmacological treatments, as there is still no specific
treatment for COVID-19. … about non-pharmacological treatments used for COVID-19, addressing …

… treatments. Based on these premises, this review aims to discuss the most updated
pharmacological treatments to … to any current and future developments in curing COVID-19 …

… injection for the treatment of mild to moderate COVID-19 in individuals over 12 years of age
and weighing no less than 40 kg who are at high risk for progression to severe COVID-19 [61,…

… COVID-19 depressive symptoms, (iii) revise the neurobiological underpinning of post-COVID-19 …
reporting potential pharmacological treatment for post-COVID-19 depressive symptoms, …